These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dermatitis following ingestion of diuretics and boric acid. Fisher RS; Middleton JC J Am Acad Dermatol; 1984 Jul; 11(1):146-7. PubMed ID: 6234332 [No Abstract] [Full Text] [Related]
3. In vivo percutaneous absorption of boron as boric acid, borax, and disodium octaborate tetrahydrate in humans: a summary. Wester RC; Hui X; Maibach HI; Bell K; Schell MJ; Northington DJ; Strong P; Culver BD Biol Trace Elem Res; 1998; 66(1-3):101-9. PubMed ID: 10050912 [TBL] [Abstract][Full Text] [Related]
4. [Liberation and in vitro skin permeation of boric acid from an ointment]. Dusemund B Arzneimittelforschung; 1987 Oct; 37(10):1197-201. PubMed ID: 3435593 [TBL] [Abstract][Full Text] [Related]
5. Probable chloracne with the use of a cow udder ointment. O'Brien TJ Australas J Dermatol; 1995 Feb; 36(1):48. PubMed ID: 7763227 [No Abstract] [Full Text] [Related]
6. In vivo percutaneous absorption of boric acid, borax, and disodium octaborate tetrahydrate in humans compared to in vitro absorption in human skin from infinite and finite doses. Wester RC; Hui X; Hartway T; Maibach HI; Bell K; Schell MJ; Northington DJ; Strong P; Culver BD Toxicol Sci; 1998 Sep; 45(1):42-51. PubMed ID: 9848109 [TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial of active chronic otitis media comparing courses of eardrops versus one-off topical treatments suitable for primary, secondary and tertiary healthcare settings. Loock JW Clin Otolaryngol; 2012 Aug; 37(4):261-70. PubMed ID: 22804826 [TBL] [Abstract][Full Text] [Related]
8. In vitro percutaneous absorption of boron as boric acid, borax, and disodium octaborate tetrahydrate in human skin: a summary. Wester RC; Hartway T; Maibach HI; Schell MJ; Northington DJ; Culver BD; Strong PL Biol Trace Elem Res; 1998; 66(1-3):111-20. PubMed ID: 10050913 [TBL] [Abstract][Full Text] [Related]
9. Hazard assessment of boric acid in toys. Craan AG; Myres AW; Green DW Regul Toxicol Pharmacol; 1997 Dec; 26(3):271-80. PubMed ID: 9441917 [TBL] [Abstract][Full Text] [Related]
11. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence. Iavazzo C; Gkegkes ID; Zarkada IM; Falagas ME J Womens Health (Larchmt); 2011 Aug; 20(8):1245-55. PubMed ID: 21774671 [TBL] [Abstract][Full Text] [Related]
12. [Safety of topical tacrolimus and pimecrolimus in children with atopic dermatitis]. Rodríguez Orozco AR; Ruiz Reyes H; Marín Hernández D Rev Alerg Mex; 2005; 52(4):171-6. PubMed ID: 16268186 [TBL] [Abstract][Full Text] [Related]
13. Nonclinical safety evaluation of boric acid and a novel borate-buffered contact lens multi-purpose solution, Biotrue™ multi-purpose solution. Lehmann DM; Cavet ME; Richardson ME Cont Lens Anterior Eye; 2010 Dec; 33 Suppl 1():S24-32. PubMed ID: 21115387 [TBL] [Abstract][Full Text] [Related]
14. Mercury intoxication after topical application of a metallic mercury ointment. Bourgeois M; Dooms-Goossens A; Knockaert D; Sprengers D; Van Boven M; Van Tittelboom T Dermatologica; 1986; 172(1):48-51. PubMed ID: 2937665 [TBL] [Abstract][Full Text] [Related]
18. Allergic contact dermatitis from dibucaine hydrochloride, chlorpheniramine maleate, and naphazoline hydrochloride in an over-the-counter topical antiseptic. Yamadori Y; Oiso N; Hirao A; Kawara S; Kawada A Contact Dermatitis; 2009 Jul; 61(1):52-3. PubMed ID: 19659969 [No Abstract] [Full Text] [Related]
19. Contact allergy to topical corticosteroids in children with atopic dermatitis. Foti C; Bonifazi E; Casulli C; Bonamonte D; Conserva A; Angelini G Contact Dermatitis; 2005 Mar; 52(3):162-3. PubMed ID: 15811035 [No Abstract] [Full Text] [Related]
20. [Side effects of some commonly used drugs in otorhinolaryngology in young children]. Reitlinger A HNO; 1967 Jul; 15(7):208-9. PubMed ID: 5608332 [No Abstract] [Full Text] [Related] [Next] [New Search]